We first conducted univariate analysis to define whether tumor stage, tumor grade, debulking status, age, or BRCA1/2 mutation status were independently associated with survival outcomes among treatment-naïve patients (Table 1; Supplementary Table 3). This evidence concerns the gene BRCA1 and neoplasm.